Ranitidine Hydrochloride/Bismuth Potassium Citrate

盐酸雷尼替丁/枸橼酸铋钾

Report date: 2024/09/05 16:38:48

Base Information

Drug NameRanitidine Hydrochloride/Bismuth Potassium Citrate
Drug Alias Name复方盐酸雷尼替丁分散片
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H2 receptor antagonists
TargetsHistamine H2 receptor
Therapy Area/IndicationsHelicobacter pylori infectionStomach UlcerDuodenal Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Ranitidine HydrochlorideBismuth Potassium Citrate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHelicobacter pylori infectionStomach UlcerDuodenal Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A